Literature DB >> 1191350

Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.

M J Reza, L Dornfeld, L S Goldberg, R Bluestone, C M Pearson.   

Abstract

Ten patients with Wegener's granulomatosis were treated with cyclophosphamide and followed for periods up to 7 years. In all cases cyclophosphamide induced complete remissions. The mean duration of remission (to date) was 38 months. Six patients have been in remission for a mean of 46 months after cyclophosphamide was discontinued; 2 have been disease-free for 7 years. Of the 10 patients treated, only 1 relapsed and she responded to a second course of cyclophosphamide. These results indicate that cyclophosphamide is the drug of choice in Wegener's granulomatosis. The long-term effectiveness of this drug suggests that it may induce permanent remissions in certain patients with Wegener's granulomatosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191350     DOI: 10.1002/art.1780180513

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

Authors:  A Harris; G Chang; M Vadas; D Gillis
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Editorial: Immunosuppressive therapy in SLE-a reappraisal.

Authors: 
Journal:  Br Med J       Date:  1976-04-10

3.  Wegener's granulomatosis presenting as theumatoid arthritis (two cases).

Authors:  M H Pritchard
Journal:  Proc R Soc Med       Date:  1976-07

Review 4.  Vasculitis and granulomatosis of the respiratory tract.

Authors:  C W Edwards
Journal:  Thorax       Date:  1982-02       Impact factor: 9.139

5.  Wegener granulomatosis with avascular necrosis of a lower extremity.

Authors:  J Lowe; A Hecton
Journal:  West J Med       Date:  1979-03

6.  Association of Wegener's granulomatosis with HLA antigens and other genetic markers.

Authors:  S S Papiha; G E Murty; A Ad'Hia; B T Mains; M Venning
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

7.  Ear, nose, and throat symptoms in subacute Wegener's granulomatosis.

Authors:  D P D'Cruz; E Baguley; R A Asherson; G R Hughes
Journal:  BMJ       Date:  1989-08-12

Review 8.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05

9.  Mesna side effects which imitate vasculitis.

Authors:  E Reinhold-Keller; J Mohr; E Christophers; K Nordmann; W L Gross
Journal:  Clin Investig       Date:  1992-08

10.  Wegener's granulomatosis in north India. An analysis of eleven patients.

Authors:  P Bambery; V Sakhuja; A Gupta; D Behera; U Kaur; S R Bhusnurmath; S K Jindal; S K Malik; S D Deodhar; K S Chugh
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.